The Atlas Arteria Group (ASX: ALX) share price is in focus today as Diamond Infraco 1 Pty Ltd, a subsidiary of IFM Global Infrastructure Fund, issued its sixth supplementary bidder's statement extending its takeover offer and updating the status of offer conditions.

Image source: Getty Images
What did Atlas Arteria report?
- The offer period for Diamond Infraco's takeover bid has been extended to 7:00pm (Sydney time) on Thursday, 25 June 2026.
- Several regulatory and material agreement conditions of the offer have been either fulfilled or waived.
- The bid remains subject to a small number of outstanding conditions, including no market fall and restrictions on distributions and major business changes.
- The new deadline for notice of the status of conditions is now 18 June 2026.
What else do investors need to know?
Diamond Infraco's extension gives Atlas Arteria shareholders a further week to consider the bid, replacing the previous closing date of 18 June 2026. Most regulatory hurdles have now been cleared, which means the offer is closer to being unconditional.
At the time of the latest statement, only a handful of conditions remain. These largely relate to market performance and ensuring Atlas Arteria does not undertake significant changes before the offer closes. This update was formally lodged with the Australian Securities and Investments Commission on 10 June 2026.
What's next for Atlas Arteria?
The focus now shifts to whether the remaining offer conditions are satisfied or waived ahead of the extended closing date. Shareholders can expect further updates by or before 18 June 2026 regarding the status of outstanding conditions.
Looking ahead, Atlas Arteria's board and shareholders will be weighing up the merits of the revised timeline and any developments in negotiations with Diamond Infraco as the offer nears its new closing date.
Atlas Arteria share price snapshot
Over the past 12 months, Atlas Arteria shares have declined 4%, trailing the S&P/ASX 200 Index (ASX: XJO) which has risen 1% over the same period.